12:00 AM
Jun 20, 2011
 |  BC Week In Review  |  Company News  |  Deals

BioPhausia, Medivir deal

Medivir completed its previously announced subsequent tender offer to acquire specialty pharma BioPhausia in a cash and stock deal....

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >